ARTICLE | Company News
Crescendo grants Zai rights to psoriasis antibody
June 1, 2018 7:05 PM UTC
Crescendo Biologics Ltd. (Cambridge, U.K.) granted Zai Lab Ltd. (NASDAQ:ZLAB) exclusive, worldwide rights to an undisclosed antibody based on its Humabody platform.
Crescendo received an upfront payment and is eligible for milestones and royalties. Zai and Crescendo each declined to discuss financial terms or details about the antibody...